Western companies refused to supply chromatographic columns to Russia - devices necessary for the development of new drugs and quality control of already registered drugs. It is difficult to find analogues of chromatographic columns of American and European production, but they are not produced in the Russian Federation. This is reported by RosSMI.

Checking the quality of medicines in the Russian Federation under threat.

The Himmed company (a distributor of reagents and equipment for laboratories) names American Agilent Technologies, Waters, Phenomenex, as well as German Merck and Macherey-Nagel among the main manufacturers of chromatographic columns..

Aleksey Kartashov, senior sales manager at Aquachrome (Waters distributor), said that the manufacturer stopped supplying chromatographic columns in early March.. Phenomenex did the same at the end of February..

Agilent announced that they decided to close their business in Russia from May 23. Merck declined to comment.. In March, the company announced that it was limiting operations in Russia to "

[see_also ids\u003d"

However, the problems of pharmaceutical manufacturers are not limited to the lack of chromatographic columns..

A much more serious problem may be with chromatographs, the import of which into the Russian Federation, unlike columns, is prohibited under EU sanctions, two distributors warn. For this reason, many pharmaceutical manufacturers will not be able to update this equipment, and will also lose service..

Recall that the Ministry of Economic Development of the Russian Federation predicted a fall in GDP, but the Russian Ministry of Finance considers the forecast optimistic. In the conservative forecast scenario, the Ministry of Economic Development expects a fall in Russia's GDP in 2022 by 12.4%.